About Index Trending news
Analyze
Top 50 Pricing
Biotherapeutics

Biotherapeutics

Work at Biotherapeutics? Add yourself to this profile

Biotherapeutics

NIMML uses disruptive innovation to tackle global health challenges in infectious, immune-mediated & chronic inflammatory diseases our site

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital
Employees

Unknown size

Locations
HQ
Headquarters
The Motley Fool

Why Northwest Biotherapeutics, Accuray, and U.S. Steel Slumped Today --

Stock markets
The Motley Fool

Why Atara Biotherapeutics Inc. Shares Are Getting Mauled Today --

Stock markets Health
$13,500,000 Venture capital (Series B)
FinSMEs

Atara Biotherapeutics Holds $13.5M Second Close of Series B Financing

$38,500,000 Venture capital (Series B)
FinSMEs

Atara Biotherapeutics Secures $38.5M in Series B Financing